Related references
Note: Only part of the references are listed.Association of Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase
Wayneho Kam et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Intravenous Thrombolytic Therapy for Treatment of Acute Ischemic Stroke in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants
David J. Seiffge
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
European Stroke Organisation - European Society for Minimally Invasive Neurological Therapy expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischaemic stroke and anterior circulation large vessel occlusion
Guillaume Turc et al.
EUROPEAN STROKE JOURNAL (2022)
Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Patients With Acute Ischemic Stroke: The DEVT Randomized Clinical Trial
Wenjie Zi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Recanalisation therapies for acute ischaemic stroke in patients on direct oral anticoagulants
David J. Seiffge et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)
Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke
Cathy S. Zhong et al.
STROKE (2021)
Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxaban
Florian Hartig et al.
NEUROLOGICAL RESEARCH AND PRACTICE (2021)
European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke
Eivind Berge et al.
EUROPEAN STROKE JOURNAL (2021)
2019 ESC Guidelines for the dignosis and management of acute pulmonary embolism development Toed in colaboration with the European Respiratory Society (ERS)
Stavros Konstantinides et al.
EUROPEAN HEART JOURNAL (2020)
Safety and efficacy of dual antiplatelet pretreatment in patients with ischemic stroke treated with IV thrombolysis: A systematic review and meta-analysis
Konark Malhotra et al.
NEUROLOGY (2020)
Stroke reperfusion therapy following dabigatran reversal with idarucizumab in a national cohort
P. Alan Barber et al.
NEUROLOGY (2020)
Idarucizumab before reperfusion therapy in stroke patients on dabigatran: No more cold sweat
Francisco A. Dias et al.
NEUROLOGY (2020)
Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants A Systematic Review and Meta-Analysis
Shima Shahjouei et al.
STROKE (2020)
Dabigatran Reversal Before Intravenous Tenecteplase in Acute Ischemic Stroke
James Beharry et al.
STROKE (2020)
Point-of-care testing of coagulation in patients treated with edoxaban
Florian Hartig et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Intravenous thrombolysis in stroke after dabigatran reversal with idarucizumab: case series and systematic review
David Giannandrea et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Cerebral Ischemia in Patients on Direct Oral Anticoagulants Plasma Levels Are Associated With Stroke Severity
Kosmas Macha et al.
STROKE (2019)
Direct Oral Anticoagulant Plasma Levels for the Management of Acute Ischemic Stroke
Armin Marsch et al.
CEREBROVASCULAR DISEASES (2019)
Idarucizumab administration in emergency situations: the Munich Registry of Reversal of Pradaxa® in clinical routine (MR REPAIR)
Clemens Kuepper et al.
JOURNAL OF NEUROLOGY (2019)
Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan
Chen-Wen Fang et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2019)
Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis?
Janja Pretnar Oblak et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2019)
Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
William J. Powers et al.
STROKE (2019)
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Borja Ibanez et al.
EUROPEAN HEART JOURNAL (2018)
Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience
Daniel Sanak et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)
Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience
Daniel Sanak et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)
Cohort profile: Thrombolysis in Ischemic Stroke Patients (TRISP): a multicentre research collaboration
Jan F. Scheitz et al.
BMJ OPEN (2018)
Prior Direct Oral Anticoagulant Therapy is Related to Small Infarct Volume and No Major Artery Occlusion in Patients With Stroke and Non-Valvular Atrial Fibrillation
Yuki Sakamoto et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany - A national case collection
Pawel Kermer et al.
INTERNATIONAL JOURNAL OF STROKE (2017)
Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)
Andrew D. Barreto et al.
STROKE (2017)
Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice
David J. Seiffge et al.
JOURNAL OF STROKE (2017)
Use of Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke Who Take Non-Vitamin K Antagonist Oral Anticoagulants Before Stroke
Ying Xian et al.
CIRCULATION (2017)
Recanalization Therapies in Acute Ischemic Stroke Patients Impact of Prior Treatment With Novel Oral Anticoagulants on Bleeding Complications and Outcome A Pilot Study
David J. Seiffge et al.
CIRCULATION (2015)
Validation assessment of risk tools to predict outcome after thrombolytic therapy for acute ischemic stroke
Robbert-Jan Van Hooff et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2014)
Rivaroxaban does not increase hemorrhage after thrombolysis in experimental ischemic stroke
Robert Ploen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Rivaroxaban and Apixaban Reduce Hemorrhagic Transformation After Thrombolysis by Protection of Neurovascular Unit in Rat
Syoichiro Kono et al.
STROKE (2014)
Safety of Intravenous Thrombolysis for Ischemic Stroke in Patients Treated with Warfarin
Michael V. Mazya et al.
ANNALS OF NEUROLOGY (2013)
Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban
T. Steiner et al.
CLINICAL RESEARCH IN CARDIOLOGY (2013)
Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia
Li Sun et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Risks of Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Receiving Warfarin and Treated With Intravenous Tissue Plasminogen Activator
Ying Xian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Increased Risk of Hemorrhagic Transformation in Ischemic Stroke Occurring During Warfarin Anticoagulation An Experimental Study in Mice
Waltraud Pfeilschifter et al.
STROKE (2011)
Blood Brain Barrier Breakdown and Repair by Src after Thrombin-Induced Injury
Da-Zhi Liu et al.
ANNALS OF NEUROLOGY (2010)
Share Paper
